Operose Advisors’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.3M Buy
7,905
+298
+4% +$51.6K 0.3% 45
2025
Q4
$1.35M Hold
7,607
0.31% 40
2025
Q3
$1.21M Hold
7,607
0.3% 44
2025
Q2
$1.07M Hold
7,607
0.3% 44
2025
Q1
$888K Buy
7,607
+250
+3% +$32.2K 0.29% 50
2024
Q4
$925K Sell
7,357
-531
-7% -$65.4K 0.32% 42
2024
Q3
$822K Hold
7,888
0.27% 52
2024
Q2
$767K Hold
7,888
0.27% 48
2024
Q1
$743K Buy
7,888
+4,100
+108% +$361K 0.25% 58
2023
Q4
$353K Sell
3,788
-682
-15% -$54.6K 0.14% 73
2023
Q3
$365K Buy
4,470
+959
+27% +$83.3K 0.14% 68
2023
Q2
$300K Buy
3,511
+254
+8% +$21.7K 0.14% 62
2023
Q1
$286K Buy
3,257
+1,128
+53% +$105K 0.14% 52
2022
Q4
$181K Sell
2,129
-225
-10% -$19.2K 0.1% 75
2022
Q3
$186K Hold
2,354
0.12% 63
2022
Q2
$179K Hold
2,354
0.13% 64
2022
Q1
$206K Buy
2,354
+230
+11% +$22.2K 0.14% 65
2021
Q4
$209K Buy
+2,124
New +$212K 0.17% 57

Other funds holding MS

Operose Advisors's MS Position: Q1 2026 in Review

Operose Advisors increased its Morgan Stanley (MS) stake by 3.9% in Q1 2026, buying an estimated $51.6K and bringing the position to 7,905 shares worth $1.3M. The position accounts for 0.3% of the portfolio, ranked #45.

Operose Advisors first reported a position in MS in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.35M in Q4 2025. 2,490 funds tracked by Wall St. Rank hold MS as of Q1 2026.

  • Operose Advisors held 7,905 shares of Morgan Stanley worth $1.3M as of Q1 2026.
  • Operose Advisors bought 298 Morgan Stanley shares in Q1 2026, an estimated $51.6K.
  • Morgan Stanley made up 0.3% of Operose Advisors's portfolio in Q1 2026, its #45 holding.
  • Operose Advisors first reported a position in Morgan Stanley in Q4 2021 and has held it in 18 quarters since.
  • Operose Advisors's Morgan Stanley position peaked at $1.35M in Q4 2025.
  • 2,490 funds tracked by Wall St. Rank held Morgan Stanley as of Q1 2026.

Based on Operose Advisors's 13F filing for Q1 2026, filed 12 May 2026.